Rockwell Medical (RMTI) Liabilities and Shareholders Equity (2010 - 2026)

Rockwell Medical (RMTI) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $57.4 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 6.42% year-over-year to $57.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $224.7 million (up 0.63% YoY) and the FY2025 annual result came in at $57.1 million, down 3.48% from the prior year.
• Liabilities and Shareholders Equity was little changed at $57.4 million in Q1 2026, from $57.1 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $59.2 million in Q4 2024 to a low of $37.4 million in Q1 2022.
• A 5-year average of $51.7 million and a median of $53.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity sank 46.1% — and 2024, when it jumped 39.41%.
• Tracing RMTI's Liabilities and Shareholders Equity over 5 years: stood at $46.6 million in 2022, then gained by 11.88% to $52.2 million in 2023, then increased by 13.48% to $59.2 million in 2024, then decreased by 3.48% to $57.1 million in 2025, then gained by 0.49% to $57.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $57.4 million (Q1 2026), $57.1 million (Q4 2025), and $57.5 million (Q3 2025), per Business Quant data.